10 Articles
10 Articles
Stopping GLP-1 drugs can mean more than just the weight you've lost. A large study of more than 333,000 people with type 2 diabetes showed that after stopping treatment, protection against heart attack, stroke and death weakened. The analysis covered drugs, which include, among others, Ozempic, Wegovy, Mounjaro and Zepbound.
The cardiovascular benefits of GLP-1 drugs may weaken after discontinuation of treatment. A new study showed how the risks varied depending on the duration of the break.
Coverage Details
Total News Sources10
Leaning Left0Leaning Right0Center8Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium









